Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Licencing Strategy -

Licencing Strategy -

posted on Feb 29, 2008 01:10PM

''The companys strong cash position and forecast for future cash flow from patent licensing allow Patriot to consider investment and M&A activities that will build a more product-focused company, complementing the ongoing licensing strategy of its valuable patent portfolio''

 

IMO We should build something new with our MMP.

 

We'd probably get sued, lol

 

e

Share
New Message
Please login to post a reply